Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Insulin degludec
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tresiba Penfill 100units/ml inj 3ml cartridges
0601012Z0BBAAAA
|
Insulin Tresiba | Insulin degludec | Endocrine System | 96,203 |
|
Tresiba FlexTouch 100units/ml inj 3ml pre-filled pens
0601012Z0BBABAB
|
Insulin Tresiba | Insulin degludec | Endocrine System | 37,236 |
|
Tresiba FlexTouch 200units/ml inj 3ml pre-filled pens
0601012Z0BBACAC
|
Insulin Tresiba | Insulin degludec | Endocrine System | 26,446 |
|
Insulin degludec 100units/ml inj 3ml pf dispos dev
0601012Z0AAABAB
|
Insulin degludec | Insulin degludec | Endocrine System | 3,881 |
|
Insulin degludec 100units/ml inj 3ml cartridges
0601012Z0AAAAAA
|
Insulin degludec | Insulin degludec | Endocrine System | 2,429 |
|
Insulin degludec 200units/ml inj 3ml pf dispos dev
0601012Z0AAACAC
|
Insulin degludec | Insulin degludec | Endocrine System | 1,448 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.